Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WARD Prospective Study - Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization

NCT05378139 is registered in ClinicalTrials.gov with University Hospital Bispebjerg and Frederiksberg as lead sponsor.

NCT NCT05378139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05378139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WARD Prospective Study - Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
Lead sponsor
University Hospital Bispebjerg and Frederiksberg
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2021
Completion date
December 22, 2025
Enrollment
3,095 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac disease, hematologic diseases, infections, oncology, pulmonary disease, surgical complication